Press release
H1N1 (Swine Influenza) - Drug Pipeline Landscape, 2022
H1N1 (Swine Influenza) - Drug Pipeline Landscape
The H1N1 flu (swine flu) is primarily caused by the H1N1 strain of the flu (influenza) virus. It is a communicable viral illness causing upper and lower respiratory tract infections.
Swine flu H1N1 infects the cells that line nose, throat and lungs. The virus enters body when contaminated droplets are inhaled or transfer live virus from a contaminated surface to eyes, nose or mouth.
Read more about H1N1 (Swine Influenza) - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/h1n1-swine-influenza-drug-pipeline-landscape-2022
The most common symptoms of H1N1 infection include difficulty in breathing, chest pain, dizziness, nasal secretions, chills, fever, cough, sore throat, decreased appetite, and in some cases and lower respiratory tract disease.
Report Highlights
Global Insight Service's, H1N1 (Swine Influenza) - Drug Pipeline Landscape, 2022 report provides an overview of the H1N1 (Swine Influenza) pipeline drugs. This report covers detailed insights on H1N1 (Swine Influenza) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. H1N1 (Swine Influenza) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31042
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.
Some of the key players involved in development of H1N1 (Swine Influenza) therapeutics are :
• Abzyme Therapeutics LLC
• Ansun Biopharma Inc
• Blue Water Vaccines Inc
• BunyaVax BV
• Chicago Biosolutions Inc
• Cidara Therapeutics Inc
• Cocrystal Pharma Inc
• Codagenix, Inc
• Collaborations Pharmaceuticals Inc
• CSL Ltd
• Curevac NV
• Dnarx LLC
• Emergent BioSolutions Inc
• Ena Respiratory Pty Ltd
• EpiVax Inc
• Genentech USA Inc
• Imutex Ltd
• Jiangsu Ab&b Biotechnology Co Ltd
• Medicago Inc
• Moderna Inc
• NanoViricides Inc
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31042/
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release H1N1 (Swine Influenza) - Drug Pipeline Landscape, 2022 here
News-ID: 2785052 • Views: …
More Releases from Global Insight Services
Synthetic Dyes Market Expected to Grow from $9.9 Billion in 2024 to $18.2 Billio …
The Synthetic Dyes Market is poised for significant growth over the next decade, driven by rising demand across textiles, food, cosmetics, and pharmaceutical industries. Synthetic dyes, chemically engineered colorants, provide vibrant, long-lasting hues that enhance product appeal and consumer satisfaction. These dyes play a crucial role in ensuring consistency and stability in color across various applications, making them indispensable in modern manufacturing processes. Innovations in dyeing technologies, coupled with the…
Software as a Medical Device Market Expected to Grow from $57.3 Billion in 2024 …
The Software as a Medical Device Market is witnessing unprecedented growth as healthcare increasingly integrates digital solutions. Software as a Medical Device (SaMD) refers to software applications that perform medical functions independently of traditional hardware devices. These applications span diagnostics, therapeutic interventions, and patient monitoring, enabling healthcare providers to deliver precise, personalized care. The market is fueled by technological advancements such as artificial intelligence, machine learning, and cloud computing, which…
Autoclaved Aerated Concrete Market Is Anticipated To Expand From $29.8 Billion I …
Market Overview
The Autoclaved Aerated Concrete Market is witnessing remarkable growth driven by the increasing global emphasis on sustainable and energy-efficient building materials. Autoclaved Aerated Concrete (AAC) is a lightweight, precast material made primarily from natural raw materials such as sand, lime, cement, and water. Its superior thermal insulation, fire resistance, and eco-friendly characteristics make it a preferred alternative to conventional concrete in modern construction. The material's versatility enables its application…
Asparagus Market Is Anticipated To Expand From $29.2 Billion In 2024 To $44.0 Bi …
Market Overview
The Asparagus Market is gaining remarkable traction worldwide, driven by the growing consumer inclination toward healthy eating habits and plant-based diets. Asparagus, recognized for its high nutritional value and versatility in culinary applications, has become a preferred choice among health-conscious consumers. The market includes a wide range of products-fresh, frozen, and processed asparagus-serving both retail and foodservice sectors. The increasing popularity of organic vegetables and the global shift toward…
More Releases for H1N1
Rise In R&D Investments Drives The H1N1 Vaccine Market: A Significant Driver Pro …
The H1N1 Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the H1N1 Vaccine Market Size and Projected Growth Rate?
The market size of the H1N1 vaccine has significantly expanded in the recent past. Its growth is projected to rise from $3.33 billion in…
H1N1 Vaccines Market Opportunity Analysis, 2018 – 2026
H1N1 influenza virus causes viral disease, commonly known as swine flu, which mostly affects the respiratory system. Swine flu is characterized by infection from H1N1 strain. Symptoms of H1N1 flu are fever, cough, sore throat, runny or stuffy nose, watery and red eyes, body aches, headache, fatigue, and diarrhea. H1N1 spreads through contact with contaminated air or geographical locations infected with virus. H1N1 infection may worsen other chronic respiratory conditions…
H1N1 Vaccination Market - Global Industry Analysis 2023
H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred as swine flu. The H1N1 virus mainly affects the respiratory system including nose, lungs and throat of the infected person. In addition to human, H1N1 virus affects various species such as birds, swine, horses etc.
The H1N1 influenza virus caused a worldwide pandemic in the recent…
H1N1 Vaccines Market Rugged Expansion Foreseen by 2021
The H1N1 Vaccines Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one…
Europe H1N1 Vaccines Market 2017
Latest market study on " Europe H1N1 Vaccines Market Report: 2017 " available with Single User Europe USD 3900 at OrbisResearch.com
The H1N1 Vaccines Market report covers the present scenario and the growth prospects of the Europe H1N1 Vaccines market for 2017-2022 The report covers the market landscape and its growth prospects over the coming years. To calculate the market size , market share, market growth, market analysis , market…
Thermo Fisher Scientific Instruments Optimize H1N1 Screening
Thermo Scientific KingFisher Flex Increases Throughput for Infectious Disease Research
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has supplied a Thermo Scientific KingFisher Flex magnetic particle processor to Labor Krone and IMOLTEC (University of Applied Sciences, Bielefeld), Germany to enable research into H1N1 screening. Using the advanced flexibility and high-speed processing capabilities of the KingFisher Flex, Dr. Carsten Tiemann, head of the department, was…
